Resveratrol and Its Role in the Management of B-Cell Malignancies—A Recent Update
暂无分享,去创建一个
G. Sethi | H. Tuli | Ginpreet Kaur | M. Chintamaneni | S. Ramniwas | Dhruv Sanjay Gupta | Vaishnavi Gadi
[1] S. Carradori,et al. Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? , 2022, Molecules.
[2] Akshay Kumar,et al. Potential role of resveratrol and its nano-formulation as anti-cancer agent , 2022, Exploration of targeted anti-tumor therapy.
[3] J. Kujawski,et al. Resveratrol Analogues as Selective Estrogen Signaling Pathway Modulators: Structure–Activity Relationship , 2022, Molecules.
[4] Huaimin Dong,et al. Gefitinib-Resveratrol Cocrystal with Optimized Performance in Dissolution and Stability. , 2022, Journal of pharmaceutical sciences.
[5] Shile Huang,et al. Resveratrol induces autophagy impeding BAFF-stimulated B-cell proliferation and survival by inhibiting the Akt/mTOR pathway. , 2022, Biochemical Pharmacology.
[6] Z. Hasan,et al. In vitro study of the effect of resveratrol purified from the skin of Iraqi black grape (Vitis vinifera) on lymphocyte cultures isolated from the blood of patients with lymphoma , 2022, Journal of Medicine and Life.
[7] K. Rehman,et al. Role of Drug Delivery System in Improving the Bioavailability of Resveratrol. , 2022, Current pharmaceutical design.
[8] M. Ganguly,et al. Resveratrol-loaded chitosan–pectin core–shell nanoparticles as novel drug delivery vehicle for sustained release and improved antioxidant activities , 2022, Royal Society Open Science.
[9] C. Matei,et al. Resveratrol Encapsulation and Release from Pristine and Functionalized Mesoporous Silica Carriers , 2022, Pharmaceutics.
[10] Jiang Yi,et al. Improved water solubility, chemical stability, antioxidant and anticancer activity of resveratrol via nanoencapsulation with pea protein nanofibrils , 2021, Food Chemistry.
[11] S. Jaglowski,et al. CAR T-cell therapy for B-cell lymphoma. , 2021, Current problems in cancer.
[12] Michael R Hamblin,et al. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects , 2021, Phytotherapy research : PTR.
[13] Junjie Chen,et al. Low-density-lipoprotein-receptor-related protein 1 mediates Notch pathway activation. , 2021, Developmental cell.
[14] G. Kanas,et al. Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020–2025 , 2021, Leukemia & lymphoma.
[15] Zhonggui He,et al. Dual Strategy for Improving the Oral Bioavailability of Resveratrol: Enhancing Water Solubility and Inhibiting Glucuronidation. , 2021, Journal of agricultural and food chemistry.
[16] M. Kersten,et al. Efficacy and safety of CD19‐directed CAR‐T cell therapies in patients with relapsed/refractory aggressive B‐cell lymphomas: Observations from the JULIET, ZUMA‐1, and TRANSCEND trials , 2021, American journal of hematology.
[17] Li Liu,et al. Solubility and physicochemical properties of resveratrol in peanut oil. , 2021, Food Chemistry.
[18] G. Sethi,et al. Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer. , 2021, Pharmacological research.
[19] B. Goh,et al. Resveratrol for cancer therapy: Challenges and future perspectives. , 2021, Cancer letters.
[20] S. Boddu,et al. Resveratrol‐loaded nanomedicines for cancer applications , 2021, Cancer reports.
[21] J. T. Lee,et al. Design and Synthesis of π-Extended Resveratrol Analogues and In Vitro Antioxidant and Anti-Inflammatory Activity Evaluation , 2021, Molecules.
[22] Jianjun Liu,et al. Resveratrol inhibits proliferation and promotes apoptosis via the androgen receptor splicing variant 7 and PI3K/AKT signaling pathway in LNCaP prostate cancer cells , 2020, Oncology letters.
[23] V. Krajka-Kuźniak,et al. Effect of methoxy stilbenes—analogs of resveratrol—on the viability and induction of cell cycle arrest and apoptosis in human myeloid leukemia cells , 2020, Molecular and Cellular Biochemistry.
[24] G. Sethi,et al. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia , 2020, Journal of Molecular Medicine.
[25] S. Hu,et al. Electrospun Resveratrol-Loaded Polyvinylpyrrolidone/Cyclodextrin Nanofibers and Their Biomedical Applications , 2020, Pharmaceutics.
[26] K. K. Mahapatra,et al. Autophagy-modulating phytochemicals in cancer therapeutics: Current evidences and future perspectives. , 2020, Seminars in cancer biology.
[27] G. Sethi,et al. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics. , 2020, Seminars in cancer biology.
[28] Jerson L. Silva,et al. Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues , 2020, Molecules.
[29] A. Martelli,et al. The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic Leukemia , 2020, International journal of molecular sciences.
[30] G. Sethi,et al. Curcumin Delivery Mediated by Bio-Based Nanoparticles: A Review , 2020, Molecules.
[31] G. Lizard,et al. Aza- and Azo-Stilbenes: Bio-Isosteric Analogs of Resveratrol , 2020, Molecules.
[32] Qing Min,et al. B Cell Lymphoma. , 2020, Advances in experimental medicine and biology.
[33] J. Chung,et al. Resveratrol-loaded chitosan-γ-poly(glutamic acid) nanoparticles: Optimization, solubility, UV stability, and cellular antioxidant activity. , 2019, Colloids and surfaces. B, Biointerfaces.
[34] Z. Kmieć,et al. The wine polyphenol resveratrol modulates autophagy and induces apoptosis in MOLT-4 and HL-60 human leukemia cells. , 2019, Journal of Physiology and Pharmacology.
[35] D. Vervandier-Fasseur,et al. The Potential Use of Resveratrol for Cancer Prevention , 2019, Molecules.
[36] E. S. Coimbra,et al. Resveratrol analogues present effective antileishmanial activity against promastigotes and amastigotes from distinct Leishmania species by multitarget action in the parasites , 2019, The Journal of pharmacy and pharmacology.
[37] S. Palma,et al. Development of solid self-emulsifying drug delivery systems (SEDDS) to improve the solubility of resveratrol. , 2019, Therapeutic delivery.
[38] M. Zanetti,et al. Comparative Evaluation of Solubility, Cytotoxicity and Photostability Studies of Resveratrol and Oxyresveratrol Loaded Nanosponges , 2019, Pharmaceutics.
[39] J. Cerhan,et al. Genetic overlap between autoimmune diseases and non‐Hodgkin lymphoma subtypes , 2019, Genetic epidemiology.
[40] B. Al‐Ani,et al. Resveratrol Pretreatment Ameliorates p53-Bax Axis and Augments the Survival Biomarker B-Cell Lymphoma 2 Modulated by Paracetamol Overdose in a Rat Model of Acute Liver Injury , 2019, Pharmacology.
[41] Wei Zhang,et al. Resveratrol chemosensitizes adriamycin‐resistant breast cancer cells by modulating miR‐122‐5p , 2019, Journal of cellular biochemistry.
[42] A. Bishayee,et al. Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. , 2019, Seminars in cancer biology.
[43] Y. Ye,et al. Relationship between CXC chemokine receptor 4 expression and prognostic significance in acute myeloid leukemia , 2019, Medicine.
[44] H. Mohammadi,et al. Regulatory Effect of Resveratrol and Prednisolone on MDR1 Protein Expression in Acute Lymphoblastic Leukemia Cell Line (CCRF-CEM) , 2019, Asian Pacific journal of cancer prevention : APJCP.
[45] L. Malaguarnera. Influence of Resveratrol on the Immune Response , 2019, Nutrients.
[46] A. Atanasov,et al. Resveratrol and Its Effects on the Vascular System , 2019, International journal of molecular sciences.
[47] D. Aebisher,et al. Health benefits of resveratrol administration. , 2019, Acta biochimica Polonica.
[48] N. Pavlović,et al. In Silico Discovery of Resveratrol Analogues as Potential Agents in Treatment of Metabolic Disorders. , 2019, Current pharmaceutical design.
[49] F. Muhammad,et al. Nanoformulations of Nutraceuticals for Cancer Treatment. , 2019, Critical Reviews in Eukaryotic Gene Expression.
[50] A. Khatkar,et al. Resveratrol in Various Pockets: A Review. , 2019, Current topics in medicinal chemistry.
[51] G. Brecchia,et al. Solid Dispersion of Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Microparticles Improves Oral Bioavailability , 2018, Nutrients.
[52] C. Matar,et al. The Immunomodulatory and Anti-Inflammatory Role of Polyphenols , 2018, Nutrients.
[53] Wen-Shin Chang,et al. Novel Combination of Arsenic Trioxide (As2O3) Plus Resveratrol in Inducing Programmed Cell Death of Human Neuroblastoma SK-N-SH Cells , 2018, Cancer Genomics & Proteomics.
[54] R. Weiss,et al. Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta-Analysis of Prospective Studies , 2018, JNCI cancer spectrum.
[55] Kyung-Chul Choi,et al. Resveratrol induced reactive oxygen species and endoplasmic reticulum stress-mediated apoptosis, and cell cycle arrest in the A375SM malignant melanoma cell line , 2018, International journal of molecular medicine.
[56] H. Ochel,et al. Combined effects of resveratrol and radiation in GH3 and TtT/GF pituitary adenoma cells , 2018, Journal of Neuro-Oncology.
[57] Behzad Baradaran,et al. Investigation of BAX and BCL2 expression and apoptosis in a resveratrol- and prednisolone-treated human T-ALL cell line, CCRF-CEM , 2018, Blood research.
[58] J. Chen,et al. Resveratrol induces autophagic apoptosis via the lysosomal cathepsin D pathway in human drug-resistant K562/ADM leukemia cells. , 2018, Experimental and therapeutic medicine.
[59] D. Brenner,et al. B-Cell Metabolic Remodeling and Cancer. , 2018, Trends in cancer.
[60] Q. Fang,et al. Resveratrol-mediated apoptosis in renal cell carcinoma via the p53/AMP‑activated protein kinase/mammalian target of rapamycin autophagy signaling pathway. , 2017, Molecular medicine reports.
[61] S. Sang,et al. Metabolism and pharmacokinetics of resveratrol and pterostilbene , 2018, BioFactors.
[62] Tingting Liu,et al. Resveratrol inhibits proliferation and migration through SIRT1 mediated post-translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells , 2017, Molecular medicine reports.
[63] Wan-Wan Lin,et al. Upregulation of FcγRIIB by resveratrol via NF-κB activation reduces B-cell numbers and ameliorates lupus , 2017, Experimental &Molecular Medicine.
[64] F. Widmer,et al. Resveratrol distinctively modulates the inflammatory profiles of immune and endothelial cells , 2017, BMC Complementary and Alternative Medicine.
[65] M. Konopleva,et al. Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside , 2017, The Korean journal of internal medicine.
[66] G. Sethi,et al. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells. , 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[67] Derek J. Norris,et al. Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors. , 2015, ACS medicinal chemistry letters.
[68] S. Sanyal,et al. Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer , 2015, Molecular and Cellular Biochemistry.
[69] A. Descoteaux,et al. Macrophage Cytokines: Involvement in Immunity and Infectious Diseases , 2014, Front. Immunol..
[70] E. Engels,et al. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study , 2014, AIDS.
[71] Luciana Mosca,et al. Chemistry, stability and bioavailability of resveratrol. , 2014, Medicinal chemistry (Shariqah (United Arab Emirates)).
[72] X. Bai,et al. Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line , 2014, Oncology letters.
[73] Rong Tsao,et al. Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems. , 2014, Food chemistry.
[74] R. de Cabo,et al. Inhibition of Breast Cancer Metastasis by Resveratrol-Mediated Inactivation of Tumor-Evoked Regulatory B Cells , 2013, The Journal of Immunology.
[75] N. Rothman,et al. A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma. , 2013, Blood.
[76] Y. Baran,et al. Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest , 2013, Hematology.
[77] F. Ghiringhelli,et al. Transport, stability, and biological activity of resveratrol , 2011, Annals of the New York Academy of Sciences.
[78] Donald J L Jones,et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. , 2010, Cancer research.
[79] O. Martínez-Maza,et al. HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma , 2010, Immunologic research.
[80] P. Dorrestein,et al. Elucidating the CXCL12/CXCR4 Signaling Network in Chronic Lymphocytic Leukemia through Phosphoproteomics Analysis , 2010, PloS one.
[81] J. Pezzuto,et al. Pleiotropic mechanisms facilitated by resveratrol and its metabolites. , 2010, The Biochemical journal.
[82] J. Pezzuto,et al. Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. , 2010, Journal of medicinal chemistry.
[83] G. Robert,et al. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. , 2010, Cancer research.
[84] Y. L. Jiang. Design, synthesis and spectroscopic studies of resveratrol aliphatic acid ligands of human serum albumin. , 2008, Bioorganic & medicinal chemistry.
[85] T. Takayama,et al. Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia , 2008, Leukemia.
[86] R. Weinshilboum,et al. Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1 , 2008, Drug Metabolism and Disposition.
[87] P. Zou,et al. Resveratrol inhibits the secretion of vascular endothelial growth factor and subsequent proliferation in human leukemia U937 cells , 2007, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[88] W. Cozen,et al. Altered Immunity as a Risk Factor for Non-Hodgkin Lymphoma , 2007, Cancer Epidemiology Biomarkers & Prevention.
[89] I. Kapetanovic,et al. Glucuronidation of trans‐resveratrol by human liver and intestinal microsomes and UGT isoforms , 2006, The Journal of pharmacy and pharmacology.
[90] M. Miksits,et al. Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1 , 2005, Xenobiotica; the fate of foreign compounds in biological systems.
[91] H. Adami,et al. Family history of hematopoietic malignancy and risk of lymphoma. , 2005, Journal of the National Cancer Institute.
[92] S. Akira,et al. Specific Inhibition of MyD88-Independent Signaling Pathways of TLR3 and TLR4 by Resveratrol: Molecular Targets Are TBK1 and RIP1 in TRIF Complex1 , 2005, The Journal of Immunology.
[93] T. Walle,et al. HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS , 2004, Drug Metabolism and Disposition.
[94] D. Goldberg,et al. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. , 2003, Clinical biochemistry.
[95] J. Reiffers,et al. Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. , 2002, Carcinogenesis.
[96] J. Magdalou,et al. Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human. , 2001, Archives of biochemistry and biophysics.
[97] J Dörrie,et al. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. , 2001, Cancer research.
[98] R. Greil,et al. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells , 2000, Cell Death and Differentiation.
[99] G. Kong,et al. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. , 1999, Cancer letters.